These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11305734)

  • 21. Platelet activation markers in patients with venous thromboembolism without predisposing factors.
    Gerdsen F; Weber M; Langer F; Eifrig B; Lindhoff-Last E
    Pathophysiol Haemost Thromb; 2005; 34(1):1-5. PubMed ID: 16293978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prolactin on platelet activation and blood clotting.
    Wahlberg J; Tillmar L; Ekman B; Lindahl TL; Landberg E
    Scand J Clin Lab Invest; 2013 Apr; 73(3):221-8. PubMed ID: 23570413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of intracellular signaling events in ADP-induced platelet aggregation.
    Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
    Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?
    Klinkhardt U; Harder S
    Semin Thromb Hemost; 2005; 31(4):400-3. PubMed ID: 16149016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk.
    van der Meijden PE; Feijge MA; Giesen PL; Huijberts M; van Raak LP; Heemskerk JW
    Thromb Haemost; 2005 Jun; 93(6):1128-36. PubMed ID: 15968399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
    Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a high-throughput ELISA assay for platelet function testing using platelet-rich plasma or whole blood.
    Salles I; Broos K; Fontayne A; Szántó T; Ruan C; Nurden AT; Vanhoorelbeke K; Deckmyn H
    Thromb Haemost; 2010 Aug; 104(2):392-401. PubMed ID: 20508902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
    Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
    Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of milrinone on platelet activation as determined by TEG platelet mapping.
    Wesley MC; McGowan FX; Castro RA; Dissanayake S; Zurakowski D; Dinardo JA
    Anesth Analg; 2009 May; 108(5):1425-9. PubMed ID: 19372315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen.
    Tunjungputri RN; Van Der Ven AJ; Schonsberg A; Mathan TS; Koopmans P; Roest M; Fijnheer R; Groot PG; de Mast Q
    AIDS; 2014 Sep; 28(14):2091-6. PubMed ID: 25265076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel.
    Gremmel T; Eslam RB; Koppensteiner R; Lang IM; Panzer S
    Cardiovasc Ther; 2013 Oct; 31(5):e40-5. PubMed ID: 23311679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.